- Home
- PRQR vs MLAC Comparison
PRQR vs MLAC Comparison
Compare PRQR & MLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- MLAC
- Stock Information
- Founded
- PRQR 2012
- MLAC 2024
- Country
- PRQR Netherlands
- MLAC United States
- Employees
- PRQR N/A
- MLAC N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- MLAC
- Sector
- PRQR Health Care
- MLAC
- Exchange
- PRQR Nasdaq
- MLAC NYSE
- Market Cap
- PRQR 179.1M
- MLAC 318.0M
- IPO Year
- PRQR 2014
- MLAC 2024
- Fundamental
- Price
- PRQR $2.35
- MLAC $10.25
- Analyst Decision
- PRQR Strong Buy
- MLAC
- Analyst Count
- PRQR 8
- MLAC 0
- Target Price
- PRQR $8.88
- MLAC N/A
- AVG Volume (30 Days)
- PRQR 357.1K
- MLAC 24.1K
- Earning Date
- PRQR 08-07-2025
- MLAC 01-01-0001
- Dividend Yield
- PRQR N/A
- MLAC N/A
- EPS Growth
- PRQR N/A
- MLAC N/A
- EPS
- PRQR N/A
- MLAC N/A
- Revenue
- PRQR $21,212,711.00
- MLAC N/A
- Revenue This Year
- PRQR N/A
- MLAC N/A
- Revenue Next Year
- PRQR N/A
- MLAC N/A
- P/E Ratio
- PRQR N/A
- MLAC $417.38
- Revenue Growth
- PRQR 85.91
- MLAC N/A
- 52 Week Low
- PRQR $1.07
- MLAC $9.94
- 52 Week High
- PRQR $4.62
- MLAC $10.28
- Technical
- Relative Strength Index (RSI)
- PRQR 66.90
- MLAC N/A
- Support Level
- PRQR $2.10
- MLAC N/A
- Resistance Level
- PRQR $2.18
- MLAC N/A
- Average True Range (ATR)
- PRQR 0.13
- MLAC 0.00
- MACD
- PRQR 0.01
- MLAC 0.00
- Stochastic Oscillator
- PRQR 56.92
- MLAC 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About MLAC MOUNTAIN LAKE ACQUISITION CORP
Mountain Lake Acquisition Corp is a blank check company.